Phase II study of mitoxantrone, aclarubicin, and diaziquone in the treatment of non-small cell lung carcinoma: an Eastern Cooperative Oncology Group study

Cancer Treat Rep. 1985 Sep;69(9):1033-4.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aclarubicin
  • Aged
  • Anaphylaxis / chemically induced
  • Anthraquinones / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Aziridines / administration & dosage
  • Benzoquinones*
  • Drug Evaluation
  • Female
  • Hematologic Diseases / chemically induced
  • Humans
  • Infusions, Parenteral
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / pathology
  • Male
  • Middle Aged
  • Mitoxantrone
  • Naphthacenes / administration & dosage

Substances

  • Anthraquinones
  • Aziridines
  • Benzoquinones
  • Naphthacenes
  • Aclarubicin
  • Mitoxantrone
  • diaziquone